12 Month Price Forecast For CTLT
Distance to CTLT Price Forecasts
CTLT Price Momentum
๐ค Considering Catalent (CTLT)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: February 7, 2025 2:13 AM UTC
CTLT Analyst Ratings & Price Targets
Currently, there are no Wall Street analyst price targets or forecasts available for CTLT (Catalent).
CTLT is currently trading at $0.00. Without active analyst coverage, investors should conduct thorough independent research and consider multiple data points beyond price targets when evaluating this stock for their portfolio.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
CTLT Analyst Consensus
CTLT Price Target Range
Latest CTLT Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for CTLT.
Date | Firm | Analyst | Rating | Change | Price Target |
---|
Stocks Similar to
The following stocks are similar to Catalent based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
(CTLT) Financial Data
has a market capitalization of $0 with a P/E ratio of 0.0x. The company generates $0 in trailing twelve-month revenue with a 0.0% profit margin.
Revenue growth is N/A quarter-over-quarter, while maintaining an operating margin of N/A and return on equity of N/A.
Valuation Metrics
Growth & Margins
Financial Health
๐ฅ Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.
(CTLT) Company Overview
(CTLT) Latest News & Analysis
Novo Holdings aims to double the size of its recently acquired contract drugmaker Catalent over five years, anticipating a focus on U.S. manufacturing under President-elect Donald Trump.
Novo Holdings' plan to expand Catalent signals confidence in U.S. manufacturing, potentially boosting revenue and market position for Novo Nordisk, impacting investor sentiment positively.
Novo Holdings has finalized its $16.5 billion acquisition of Catalent following the completion of all regulatory conditions.
Novo Holdings' $16.5 billion acquisition of Catalent signifies a consolidation in the pharmaceutical sector, likely impacting market competition, stock valuations, and potential growth opportunities.
Novo Holdings Completes Acquisition of Catalent
1 month agoNovo Holdings has completed its acquisition of Catalent, Inc. for approximately $16.5 billion in cash. Alessandro Maselli will continue as President and Chief Executive Officer.
Catalent's acquisition by Novo Holdings for $16.5 billion signals a significant consolidation in the life sciences sector, potentially impacting market dynamics, competition, and investor sentiment.
Lennox International Inc. will replace Catalent Inc. in the S&P 500, and BILL Holdings Inc. will take Lennox's place in the S&P MidCap 400, effective December 23, 2024.
Changes in index constituents can impact stock prices and investor sentiment. Lennox's move to the S&P 500 may attract more institutional investment, while Catalent's removal could lead to selling pressure.
Catalent and Novo Holdings Fulfill All Regulatory Closing Conditions for Pending Transaction
1 month agoCatalent, Inc. and Novo Holdings have met all regulatory conditions for their pending transaction, expecting to finalize the deal in the coming days.
The completion of regulatory conditions signals progress in Catalent and Novo Holdings' transaction, potentially impacting stock performance and future growth strategies in the life sciences sector.
Regulatory conditions on Novo Holdings' $16.5 bln Catalent deal fulfilled, companies say
1 month agoNovo Holdings' $16.5 billion acquisition of Catalent has met all regulatory conditions and is expected to close in the coming days.
The completion of Novo Holdings' acquisition of Catalent enhances market position and growth potential, likely impacting stock performance and investor sentiment positively.
Frequently Asked Questions About CTLT Stock
What is 's (CTLT) stock forecast for 2025?
Analyst forecasts for (CTLT) are not currently available. The stock is trading at $0.00.
Is CTLT stock a good investment in 2025?
Analyst ratings for CTLT are not currently available. The stock is currently trading at $0.00. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for CTLT stock?
Price predictions from Wall Street analysts for CTLT are not currently available. The stock is trading at $0.00.
What is 's business model?
N/A
What is the highest forecasted price for CTLT ?
Price targets from Wall Street analysts for CTLT are not currently available. The stock is trading at $0.00.
What is the lowest forecasted price for CTLT ?
Price targets from Wall Street analysts for CTLT are not currently available. The stock is trading at $0.00.
What is the overall CTLT consensus from analysts for ?
Analyst ratings for CTLT are not currently available. The stock is trading at $0.00.
How accurate are CTLT stock price projections?
Stock price projections, including those for , are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.